&nbsp;

Dec 1969

Drug

octreotide

Other Name(s): Sandostatin® (multiple brands available) , Sandostatin® LAR™ (Novartis)

Quick Link(s):

Dec 1969

Drug

methotrexate

Quick Link(s):

Nov 2022

Drug

osimertinib

Other Name(s): Tagrisso®

Quick Link(s):

Dec 1969

Drug

midostaurin

Other Name(s): Rydapt®

Quick Link(s):

Dec 1969

Regimen

MEGE

Cancer Type:

Breast

Intent: Palliative

Funding:

ODB - General Benefit

megestrol - oral tablets

Drugs Used:

megestrol

Quick Link(s):

Regimen Monograph

Regimen

MVAC(HD)

Cancer Type:

Genitourinary,

Bladder / Urothelial

Intent: Neoadjuvant, Adjuvant, Palliative

Drugs Used:

Quick Link(s):

Regimen Monograph

Sep 2022

Regimen

MXNTPRED

Cancer Type:

Genitourinary,

Prostate

Intent: Palliative

Funding:

ODB - General Benefit

prednisone

Drugs Used:

mitoXANTRONE,

prednisone

Quick Link(s):

Regimen Monograph

Regimen

MTRX

Cancer Type:

Gynecologic,

Gestational Trophoblastic Disease

Intent: Curative

Drugs Used:

methotrexate

Quick Link(s):

Regimen Monograph

Oct 2017

Regimen

OCTR

Cancer Type:

Gastrointestinal,

Neuroendocrine (GI),

Lung,

Neuroendocrine (Lung)

Intent: Palliative

Funding:

ODB - General Benefit

octreotide

Drugs Used:

octreotide

Quick Link(s):

Regimen Monograph

Regimen

MTTN

Cancer Type:

Endocrine,

Adrenal

Intent: Adjuvant

Funding:

ODB - General Benefit

mitotane

Drugs Used:

mitotane

Quick Link(s):

Regimen Monograph

Nov 2021

Regimen

MELPPRED

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Funding:

ODB - General Benefit

melphalan - oral tablets

ODB - General Benefit

prednisone

Drugs Used:

melphalan,

prednisone